Variable Linezolid Exposure in Intensive Care Unit PatientsPossible Role of Drug-Drug Interactions

被引:23
|
作者
Toepper, Christoph [1 ]
Steinbach, Catherine L. [1 ]
Dorn, Christoph [2 ]
Kratzer, Alexander [3 ]
Wicha, Sebastian G. [4 ]
Schleibinger, Michael [5 ]
Liebchen, Uwe [5 ]
Kees, Frieder [6 ]
Salzberger, Bernd [5 ]
Kees, Martin G. [1 ,7 ]
机构
[1] Charite Univ Med Berlin, Dept Anaesthesiol & Intens Care, Campus Benjamin Franklin,Hindenburgdamm 30, D-12200 Berlin, Germany
[2] Univ Regensburg, Dept Clin Pharm, Inst Pharm, Regensburg, Germany
[3] Univ Hosp Regensburg, Hosp Pharm, Regensburg, Germany
[4] Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden
[5] Univ Hosp Regensburg, Dept Internal Med 1, Regensburg, Germany
[6] Univ Regensburg, Dept Pharmacol, Regensburg, Germany
[7] Free Univ Berlin, Inst Pharm, Dept Clin Pharm & Biochem, Berlin, Germany
关键词
critical illness; pharmacokinetics; Gram-positive infection; antimicrobial agents; CRITICALLY-ILL PATIENTS; UNBOUND FRACTION; PROTEIN-BINDING; THYROID-HORMONE; P-GLYCOPROTEIN; PHARMACOKINETICS; PLASMA; PATIENT; SAFETY; UNDEREXPOSURE;
D O I
10.1097/FTD.0000000000000324
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background:Standard doses of linezolid may not be suitable for all patient groups. Intensive care unit (ICU) patients in particular may be at risk of inadequate concentrations. This study investigated variability of drug exposure and its potential sources in this population.Methods:Plasma concentrations of linezolid were determined by high-performance liquid chromatography in a convenience sample of 20 ICU patients treated with intravenous linezolid 600 mg twice daily. Ultrafiltration applying physiological conditions (pH 7.4/37 degrees C) was used to determine the unbound fraction. Individual pharmacokinetic (PK) parameters were estimated by population PK modeling. As measures of exposure to linezolid, area under the concentration-time curve (AUC) and trough concentrations (C-min) were calculated and compared with published therapeutic ranges (AUC 200-400 mg*h/L, C-min 2-10 mg/L). Coadministered inhibitors or inducers of cytochrome P450 and/or P-glycoprotein were noted.Results:Data from 18 patients were included into the PK evaluation. Drug exposure was highly variable (median, range: AUC 185, 48-618 mg*h/L, calculated C-min 2.92, 0.0062-18.9 mg/L), and only a minority of patients had values within the target ranges (6 and 7, respectively). AUC and C-min were linearly correlated (R = 0.98), and classification of patients (underexposed/within therapeutic range/overexposed) according to AUC or C-min was concordant in 15 cases. Coadministration of inhibitors was associated with a trend to higher drug exposure, whereas 3 patients treated with levothyroxine showed exceedingly low drug exposure (AUC approximate to 60 mg*h/L, C-min <0.4 mg/L). The median unbound fraction in all 20 patients was 90.9%.Conclusions:Drug exposure after standard doses of linezolid is highly variable and difficult to predict in ICU patients, and therapeutic drug monitoring seems advisable. PK drug-drug interactions might partly be responsible and should be further investigated; protein binding appears to be stable and irrelevant.
引用
收藏
页码:573 / 578
页数:6
相关论文
共 50 条
  • [1] Evaluation of potential drug-drug interactions in intensive care unit
    Dagdelen, M. S.
    Gulen, D.
    Ceylan, I
    Girgin, N. K.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (18) : 5801 - 5806
  • [2] Frequency and nature of drug-drug interactions in the intensive care unit
    Askari, Marjan
    Eslami, Saied
    Louws, Mathijs
    Wierenga, Peter C.
    Dongelmans, Dave A.
    Kuiper, Rob A.
    Abu-Hanna, Ameen
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 (04) : 430 - 437
  • [3] Predictors of Potential Drug-Drug Interactions in Patients at Intensive Care Unit
    Ilickovic, Ivana
    Orlandic-Cejovic, Vesna
    Tanaskovic, Sanja
    Jankovic, Slobodan M.
    [J]. ACTA FACULTATIS MEDICAE NAISSENSIS, 2019, 36 (03) : 188 - 197
  • [4] Drug-drug interactions in intensive care unit: A point prevalence study
    Bahap, Melda
    Kara, Emre
    Bayraktar-Ekincioglu, Aygin
    Topeli, Arzu
    Demirkan, Kutay
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (01) : 307 - 307
  • [5] Drug-drug interactions in the intensive care unit: Do they really matter?
    Vanham, D.
    Spinewine, A.
    Hantson, Ph.
    Wittebole, X.
    Wouters, D.
    Sneyers, B.
    [J]. JOURNAL OF CRITICAL CARE, 2017, 38 : 97 - 103
  • [6] Potential Drug-Drug Interactions in the Pediatric Intensive Care Unit of a Tertiary Care Hospital
    Rao, Chandini
    Shenoy, Varadaraj
    Udaykumar, Padmaja
    [J]. JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2019, 10 (02) : 63 - 68
  • [7] Potential drug-drug interactions in a medical intensive care unit of a university hospital
    Gulcebi Idriz Oglu, Medine
    Kucukibrahimoglu, Esra
    Karaalp, Atila
    Sarikaya, Ozlem
    Demirkapu, Mahluga
    Onat, Filiz
    Goren, Mehmet Zafer
    [J]. TURKISH JOURNAL OF MEDICAL SCIENCES, 2016, 46 (03) : 812 - 819
  • [8] Identification and Assessment of Potential Drug-Drug Interactions in Intensive Care Unit Patients
    Wagh, Bhavika Ravindra
    Godbole, Deepa Dhananjay
    Deshmukh, Shubham Shivaji
    Iyer, Shivakumar
    Deshpande, Prasanna R.
    [J]. INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2019, 23 (04) : 170 - 174
  • [9] Corrected QT interval for possible drug-drug interactions in the intensive care unit
    Armahizer, Michael J.
    Seybert, Amy L.
    Smithburger, Pamela L.
    Kane-Gill, Sandra L.
    [J]. JOURNAL OF CRITICAL CARE, 2013, 28 (06) : 1107 - 1107
  • [10] Drug-drug interactions in an intensive care unit and comparison of updates in two databases
    Riera, Pau
    Sole, Nuria
    Carlos Suarez, Juan
    Andrea Lopez, Paula
    Fonts, Nuria
    Rodriguez-Farre, Nuria
    Fernandez de Gamarra-Martinez, Edurne
    Moran, Indalecio
    [J]. FARMACIA HOSPITALARIA, 2022, 46 (05) : 290 - 295